Print and Online Coverage
- Wall Street Journal – Biotech entrepreneur Chris Varma scores $67 million for Frontier Medicines
- San Francisco Business Times – How an entrepreneur with UC technology is on the trail toward the ‘undruggable’
- Silicon Valley Business Journal – How an entrepreneur with UC technology is on the trail toward the ‘undruggable’
- BioCentury – Frontier aims for previously unreachable ‘hot spot’ targets with $67M series A
- Fierce Biotech – Frontier Medicines launches with $67M and biotech veteran Varma as CEO
- Science Business – Company launches attacking cancer proteins, lands $67M
- EndPointsNews – Chris Varma unveils MPM’s latest start-up – eying ‘undruggable’ cancer targets and powered by machine learning, $67M
- Chemical and Engineering News – Frontier Medicines launches with $67 million in funding
- Bio Space – Frontier Medicines closes $67 Million Series A, Will Focus on Chemoproteomics
- Finsmes – Frontier Medicines Closes $67M series A Financing
- PE Hub Network – Frontier Medicines picks up $67 mln
- Becker’s Healthcare AI reached record-high $846M funding in Q2 Progress in Lending Association: Early Stage Funding Rounds Accounted For 75.6% Of Total Investment The Pharma Letter – Frontier Medicines launches with $67 million financing
- Axios – Top of the Morning/Venture Capital Deals: Frontier Medicines
- MedCity News – Frontier Medicines launches with $67M Series A, hopes to go after ‘undruggable’ targets
- Silicon Valley Business Journal – The Funded: Led by three megarounds, Bay Area startups haul in $800M in venture funding
- BioSpace – Latham & Watkins Advises Frontier Medicines in $67 Million Series A Financing for Development of Novel Medicines
- BioToday – Japan, article is behind a paywall and is not included in the clips section at the end of this report
- Wall Street Journal – VC Daily: Midyear Fundraising Bounty | Fifty Years Is Refueling | VC: The History
- Wall Street Journal – Life Sciences Venture Firm MPM Capital Seeks $200 Million Oncology Fund
- Investank – Latham & Watkins Advises Frontier Medicines in $67 Million Series A Financing for Development of Novel Medicines
- MedCity News – StartUPDATES: The latest healthcare startup news from MedCitizens
- MedCity News – RA Capital Management closes $308M venture capital fund
- MedCity News – Revolution Medicines secures $100M equity round, aiming for hard-to-reach oncology targets
- MedCity News – Kronos Bio bags $105M in Series A round for platform technology
- BioPharm Guy – Frontier Medicines
- BioPortfolio – Frontier Medicines gets $67mm in Series A round
- Fierce Biotech – Chutes & Ladders–Frontier Medicines launches with biotech vet as CEO
- Global University Venturing – Frontier faces down $67m
- CB Insights – This Week In AI: Apple and Uber Acquire AV Startups, CMU Partners With Argo AI, MIT Researchers Turn Proteins Into Music
- FierceBiotech – Frontier Medicines bolsters leadership team with new CSO, tech hires
- Med City News – Amgen cancer drug with ‘undruggable’ target shows more progress
- Biocentury – R&D chief leaving Adaptimmune; plus Frontier Medicines builds out team and more
- Wall Street Journal – VC Daily: ThredUp Deal Near; Impossible Boosts Production; & more
- Fierce Biotech – Chutes & Ladders
- Exome – Frontier Medicines Adds Kevin Webster, Johannes Hermann to C-Suite
- Exome – Bio Roundup
- PE Hub Network – Frontier Medicines adds three to executive team
- PE Hub Network – On the move: Ares hires Joel Holsinger as co-head of alternative credit
- Becker’s – Healthcare AI reached record-high $846M funding in Q2
- Progress in Lending Association – Early Stage Funding Rounds Accounted For 75.6% Of Total Investment